Cannabidiol (CBD) Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	160 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224290

Best Price Guarantee
Price	from $4,850
Length	160 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224290

Cannabidiol (CBD) Market

Growth Factors of Cannabidiol Market

The cannabidiol market size was valued at USD 7.59 billion in 2023, and the market is now projected to grow from USD 11.16 billion in 2024 to USD 202.45 billion by 2032, exhibiting a CAGR of 43.66% during the forecast period of 2024-2032.

The COVID-19 occurrence and dealings executed by numerous governments such as social isolation and lockdown have led to worsening of the market. The food services segment and other businesses such as the bakery, drink portions, and dairy have witnessed a massive drop in their income generation.

The promptly rising medicinal industry universally identifies the significance and aids of cannabis and its by-products. CBD is one of the key components of cannabis implemented by the pharmaceutical industry to deal health safety declaration over numerous ailments. It has properties such as plant-based in nature and natural substitutes to numerous conventional medicines that are enthusiastically promoted among producers and customers globally. Thus, the governments are approving its efficacy in medications and other medicinal therapies, which is projected to enlarge and upsurge the sales and distribution of these products which will upsurge the cannabidiol market growth.

Customers seek advanced and healthy nutrition products enhanced with nutrients for attaining health goals and avoid damages such as irritation, discomfort, and others. The makers are presenting products infused with innovative components such as CBD oil. Cannabidiol oils are the permitted and non-psychoactive component of cannabis that has captured numerous industries such as nutrition, fitness products, pharmacy & beauty, and others.

Comprehensive Analysis of Cannabidiol Market

The market can be segmented in various ways, depending on the focus of analysis such as by source and by application. Based on by source, the market is classified into marijuana, hemp. Based on application, the market is segmented into pharmaceuticals, food & beverages, pet care, cosmetics, others.

Asia Pacific region is dominating the cannabidiol market share due to growing legalization and approvals of cannabidiol to use in numerous products deal numerous producers potential prospects to function in the market.

The key players are enthusiastically contributing in planned events that are targeted at maintaining durable market position and growing market share by merger, partnerships and others. These players include Medical Marijuana Inc. (California, U.S.), Cannoid, LLC (Colorado, U.S), Isodiol International Inc. (Vancouver, Canada), ENDOCA (Chicago, U.S.), Folium Biosciences (Texas, U.S.), Aurora Cannabis Inc. (Edmonton, Canada), Pharmahemp d.o.o (Slovenia, Europe), Elixinol Global (Sydney, Australia), CV Sciences (California, U.S.), Medterra CBD (California, U.S.) these market players spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market.

In February 2024, Jublee CBD, a global firm that produces personal care products, offered numerous CBD skincare lines, comprising body butters and bath salts.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Unit Value (USD Billion)

Growth Rate CAGR of 43.66% from 2024 to 2032

Segmentation By Source

Marijuana
Hemp

By Application

Pharmaceuticals
Food and Beverages
Pet Care
Cosmetics
Others

By Region

North America (By Source, Application, and By Country)
The U.S. (By Source)
Canada (By Source)
Mexico (By Source)
Europe (By Source, Application, and By Country)
Russia (By Source)
Austria (By Source)
Italy (By Source)
Germany (By Source)
U.K. (By Source)
Rest of Europe (Source)
Asia Pacific (By Source, Application, and By Country)
China (By Source)
Australia (By Source)
India (By Source)
Japan (By Source)
Rest of Asia Pacific (By Source)
South America (By Source, Application, and By Country)
Argentina (By Source)
Brazil (By Source)
Rest of South America (By Source)
The Middle East and Africa (By Source, Application, and By Country)
South Africa (By Source)
UAE (By Source)
Rest of ME&A (By Source)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Emerging Trends
4. Key Insights: 4.1. Overview on Cannabis Markets; 4.2. Supply Chain and Industry SWOT Analysis; 4.3. Global Cannabidiol Regulatory Analysis; 4.4. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches; 4.5. Impact of COVID-19; 4.5.1. Challenges in Supply Chain; 4.5.2. Efforts to Mitigate the Challenges
5. Global Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 5.1. Key Findings / Summary; 5.2. Market Size Estimates and Forecast; 5.2.1. By Source; 5.2.1.1. Marijuana; 5.2.1.2. Hemp; 5.2.2. By Application; 5.2.2.1. Food & Beverages; 5.2.2.2. Pharmaceuticals; 5.2.2.3. Pet Care; 5.2.2.4. Cosmetics; 5.2.2.5. Others; 5.2.3. By Region; 5.2.3.1. North America; 5.2.3.2. Europe; 5.2.3.3. Asia Pacific; 5.2.3.4. South America; 5.2.3.5. Middle East & Africa
6. North America Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 6.1. Key Findings / Summary; 6.2. Market Size Estimates and Forecast; 6.2.1. By Source; 6.2.1.1. Marijuana; 6.2.1.2. Hemp; 6.2.2. By Application; 6.2.2.1. Food & Beverages; 6.2.2.2. Pharmaceuticals; 6.2.2.3. Pet Care; 6.2.2.4. Cosmetics; 6.2.2.5. Others; 6.2.3. By Country (Value); 6.2.3.1. U.S; 6.2.3.1.1. By Source (Value); 6.2.3.1.1.1. Marijuana; 6.2.3.1.1.2. Hemp; 6.2.3.2. Canada; 6.2.3.2.1. By Source (Value); 6.2.3.2.1.1. Marijuana; 6.2.3.2.1.2. Hemp
7. Europe Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 7.1. Key Findings / Summary; 7.2. Market Size Estimates and Forecast; 7.2.1. By Source; 7.2.1.1. Marijuana; 7.2.1.2. Hemp; 7.2.2. By Application; 7.2.2.1. Food & Beverages; 7.2.2.2. Pharmaceuticals; 7.2.2.3. Pet Care; 7.2.2.4. Cosmetics; 7.2.2.5. Others; 7.2.3. By Country (Value); 7.2.3.1. Russia; 7.2.3.1.1. By Source (Value); 7.2.3.1.1.1. Marijuana; 7.2.3.1.1.2. Hemp; 7.2.3.2. Austria; 7.2.3.2.1. By Source (Value); 7.2.3.2.1.1. Marijuana; 7.2.3.2.1.2. Hemp; 7.2.3.3. Italy; 7.2.3.3.1. By Source (Value); 7.2.3.3.1.1. Marijuana; 7.2.3.3.1.2. Hemp; 7.2.3.4. Germany; 7.2.3.4.1. By Source (Value); 7.2.3.4.1.1. Marijuana; 7.2.3.4.1.2. Hemp; 7.2.3.5. U.K.; 7.2.3.5.1. By Source (Value); 7.2.3.5.1.1. Marijuana; 7.2.3.5.1.2. Hemp; 7.2.3.6. Rest of Europe; 7.2.3.6.1. By Source (Value); 7.2.3.6.1.1. Marijuana; 7.2.3.6.1.2. Hemp
8. Asia Pacific Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 8.1. Key Findings / Summary; 8.2. Market Size Estimates and Forecast; 8.2.1. By Source; 8.2.1.1. Marijuana; 8.2.1.2. Hemp; 8.2.2. By Application; 8.2.2.1. Food & Beverages; 8.2.2.2. Pharmaceuticals; 8.2.2.3. Pet Care; 8.2.2.4. Cosmetics; 8.2.2.5. Others; 8.2.3. By Country (Value); 8.2.3.1. China; 8.2.3.1.1. By Source (Value); 8.2.3.1.1.1. Marijuana; 8.2.3.1.1.2. Hemp; 8.2.3.2. Australia; 8.2.3.2.1. By Source (Value); 8.2.3.2.1.1. Marijuana; 8.2.3.2.1.2. Hemp; 8.2.3.3. India; 8.2.3.3.1. By Source (Value); 8.2.3.3.1.1. Marijuana; 8.2.3.3.1.2. Hemp; 8.2.3.4. Japan; 8.2.3.4.1. By Source (Value); 8.2.3.4.1.1. Marijuana; 8.2.3.4.1.2. Hemp; 8.2.3.5. Rest of APAC; 8.2.3.5.1. By Source (Value); 8.2.3.5.1.1. Marijuana; 8.2.3.5.1.2. Hemp
9. South America Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 9.1. Key Findings / Summary; 9.2. Market Size Estimates and Forecast; 9.2.1. By Source; 9.2.1.1. Marijuana; 9.2.1.2. Hemp; 9.2.2. By Application; 9.2.2.1. Food & Beverages; 9.2.2.2. Pharmaceuticals; 9.2.2.3. Pet Care; 9.2.2.4. Cosmetics; 9.2.2.5. Others; 9.2.3. By Country (Value); 9.2.3.1. Argentina; 9.2.3.1.1. By Source (Value); 9.2.3.1.1.1. Marijuana; 9.2.3.1.1.2. Hemp; 9.2.3.2. Brazil; 9.2.3.2.1. By Source (Value); 9.2.3.2.1.1. Marijuana; 9.2.3.2.1.2. Hemp; 9.2.3.3. Rest of South America; 9.2.3.3.1. By Source (Value); 9.2.3.3.1.1. Marijuana; 9.2.3.3.1.2. Hemp
10. Middle East & Africa Cannabidiol Market Analysis, Insights and Forecast, 2019-2032: 10.1. Key Findings / Summary; 10.2. Market Size Estimates and Forecast; 10.2.1. By Source; 10.2.1.1. Marijuana; 10.2.1.2. Hemp; 10.2.2. By Application; 10.2.2.1. Food & Beverages; 10.2.2.2. Pharmaceuticals; 10.2.2.3. Pet Care; 10.2.2.4. Cosmetics; 10.2.2.5. Others; 10.2.3. By Country (Value); 10.2.3.1. South Africa; 10.2.3.1.1. By Source (Value); 10.2.3.1.1.1. Marijuana; 10.2.3.1.1.2. Hemp; 10.2.3.2. UAE; 10.2.3.2.1. By Source (Value); 10.2.3.2.1.1. Marijuana; 10.2.3.2.1.2. Hemp; 10.2.3.3. Rest of ME&A; 10.2.3.3.1. By Source (Value); 10.2.3.3.1.1. Marijuana
11. Competitive Matrix: 11.1. Business Strategies Adopted by Leading Players; 11.2. Global Cannabidiol Market Revenue Share/Ranking Analysis, By Key Manufacturer
12. Company Profiles: 12.1. Medical Marijuana Inc.; 12.1.1. Overview; 12.1.2. Description; 12.1.3. Source Portfolio; 12.1.4. Financials (Data as available in public domain and/or on paid databases); 12.1.5. Recent Developments; 12.2. Cannoid LLC; 12.2.1. Overview; 12.2.2. Description; 12.2.3. Source Portfolio; 12.2.4. Financials (Data as available in public domain and/or on paid databases); 12.2.5. Recent Developments; 12.3. Isodiol International Inc.; 12.3.1. Overview; 12.3.2. Description; 12.3.3. Source Portfolio; 12.3.4. Financials (Data as available in public domain and/or on paid databases); 12.3.5. Recent Developments; 12.4. Folium Biosciences; 12.4.1. Overview; 12.4.2. Description; 12.4.3. Source Portfolio; 12.4.4. Financials (Data as available in public domain and/or on paid databases); 12.4.5. Recent Developments; 12.5. Aurora Cannabis, Inc.; 12.5.1. Overview; 12.5.2. Description; 12.5.3. Source Portfolio; 12.5.4. Financials (Data as available in public domain and/or on paid databases); 12.5.5. Recent Developments; 12.6. Acqua Minerale San Benedetto SpA; 12.6.1. Overview; 12.6.2. Description; 12.6.3. Source Portfolio; 12.6.4. Financials (Data as available in public domain and/or on paid databases); 12.6.5. Recent Developments; 12.7. Pharmahemp d.o.o; 12.7.1. Overview; 12.7.2. Description; 12.7.3. Source Portfolio; 12.7.4. Financials (Data as available in public domain and/or on paid databases); 12.7.5. Recent Developments; 12.8. ENDOCA; 12.8.1. Overview; 12.8.2. Description; 12.8.3. Source Portfolio; 12.8.4. Financials (Data as available in public domain and/or on paid databases); 12.8.5. Recent Developments; 12.9. Elixinol LLC.; 12.9.1. Overview; 12.9.2. Description; 12.9.3. Source Portfolio; 12.9.4. Financials (Data as available in public domain and/or on paid databases); 12.9.5. Recent Developments; 12.10. CV Sciences; 12.10.1. Overview; 12.10.2. Description; 12.10.3. Source Portfolio; 12.10.4. Financials (Data as available in public domain and/or on paid databases); 12.10.5. Recent Developments
13. Strategic Recommendations
14. Appendix